State of Wyoming’s ANI Pharmaceuticals ANIP Stock Holding History

State of Wyoming’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-768	Closed	-$50.1K	–	1831
2025 Q2	$50.1K	Buy	+768	New	+$50K	0.01%	1572
2022 Q3	–	Sell	-721	Closed	-$21K	–	1522
2022 Q2	$21K	Buy	721 +306	+74%	+$8.83K	0.01%	1398
2022 Q1	$12K	Buy	415 +60	+17%	+$2.24K	0.01%	1581
2021 Q4	$16K	Sell	355 -6	-2%	-$258	0.01%	1559
2021 Q3	$12K	Buy	361 +81	+29%	+$2.52K	0.01%	1002
2021 Q2	$10K	Buy	+280	New	+$9.53K	0.01%	1012

Other funds holding ANIP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State of Wyoming's ANIP Position: Q3 2025 in Review

State of Wyoming sold out of ANI Pharmaceuticals (ANIP) in Q3 2025, closing a stake of 768 shares — an estimated $50.1K sold.

State of Wyoming first reported a position in ANIP in Q2 2021 and held it in 6 quarters. The position peaked at $50.1K in Q2 2025. 269 funds tracked by Wall St. Rank hold ANIP as of Q3 2025.

State of Wyoming reported no remaining ANI Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
State of Wyoming sold 768 ANI Pharmaceuticals shares in Q3 2025, an estimated $50.1K.
State of Wyoming first reported a position in ANI Pharmaceuticals in Q2 2021 and held it in 6 quarters.
State of Wyoming's ANI Pharmaceuticals position peaked at $50.1K in Q2 2025.
269 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2025.

Based on State of Wyoming's 13F filing for Q3 2025, filed 4 Nov 2025.